Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies.
作者信息
Borgland Stephanie L, Neyens Drew M
机构信息
From the Hotchkiss Brain Institute, University of Calgary, Calgary, Alb. (Borgland, Neyens)
From the Hotchkiss Brain Institute, University of Calgary, Calgary, Alb. (Borgland, Neyens).
出版信息
J Psychiatry Neurosci. 2022 Jun 15;47(3):E218-E221. doi: 10.1503/jpn.220090. Print 2022 May-Jun.
Abstract
摘要
相似文献
1
Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies.用于治疗肥胖症和饮食失调的5-羟色胺能致幻剂疗法：对新兴研究的潜在期望与注意事项
J Psychiatry Neurosci. 2022 Jun 15;47(3):E218-E221. doi: 10.1503/jpn.220090. Print 2022 May-Jun.
2
Complexities of psychedelics for therapeutic use in obesity and eating disorders.用于肥胖症和饮食失调治疗的迷幻剂的复杂性。
J Psychiatry Neurosci. 2022 Oct 25;47(5):E366. doi: 10.1503/jpn.220135-l. Print 2022 Sep-Oct.
3
Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders.饮食失调中迷幻剂治疗与研究的观点：一项针对饮食失调患者的基于网络的问卷调查研究。
J Integr Neurosci. 2021 Sep 30;20(3):551-560. doi: 10.31083/j.jin2003059.
4
Psychedelic-Assisted Therapy for People with Eating Disorders.针对饮食失调患者的迷幻辅助疗法。
Curr Psychiatry Rep. 2022 Dec;24(12):767-775. doi: 10.1007/s11920-022-01394-5. Epub 2022 Nov 14.
5
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.迷幻剂在治疗进食障碍中的作用：原理和潜在机制。
Eur Neuropsychopharmacol. 2023 Oct;75:1-14. doi: 10.1016/j.euroneuro.2023.05.008. Epub 2023 Jun 21.
6
Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review.迷幻药治疗进食障碍的观点和初步经验：系统范围界定综述。
Eur Eat Disord Rev. 2024 Sep;32(5):980-1001. doi: 10.1002/erv.3101. Epub 2024 May 23.
7
Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder.报告饮食障碍的个体中，迷幻剂对抑郁和幸福感评分的积极影响。
Eat Weight Disord. 2021 May;26(4):1265-1270. doi: 10.1007/s40519-020-01000-8. Epub 2020 Sep 8.
8
Nourishing the Spirit: Exploratory Research on Ayahuasca Experiences along the Continuum of Recovery from Eating Disorders.滋养精神：探索沿着从进食障碍中恢复的连续统体验圣佩德罗草药的研究。
J Psychoactive Drugs. 2017 Nov-Dec;49(5):427-435. doi: 10.1080/02791072.2017.1361559. Epub 2017 Sep 12.
9
Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder.迷幻剂在治疗饮食障碍和躯体变形障碍中的应用。
J Psychopharmacol. 2023 Jan;37(1):3-13. doi: 10.1177/02698811221140009. Epub 2022 Dec 14.
10
The Intricate Interaction Between Expectations and Therapeutic Outcomes of Psychedelic Agents.迷幻剂的期望与治疗效果之间的复杂相互作用。
JAMA Psychiatry. 2023 Sep 1;80(9):867-868. doi: 10.1001/jamapsychiatry.2023.1412.
引用本文的文献
1
Ketamine-assisted therapy within a community of practice: a novel approach to disordered eating.实践社区中的氯胺酮辅助治疗：一种治疗饮食失调的新方法。
Ther Adv Psychopharmacol. 2025 Jul 14;15:20451253251356980. doi: 10.1177/20451253251356980. eCollection 2025.
2
The compulsive eating paradigm: can psychedelics help in treating obesity?强迫性进食模式：迷幻药能帮助治疗肥胖症吗？
J Eat Disord. 2025 Apr 7;13(1):59. doi: 10.1186/s40337-024-01186-7.
3
The Role of Music in Psychedelic-Assisted Therapy: A Comparative Analysis of Neuroscientific Research, Indigenous Entheogenic Ritual, and Contemporary Care Models.音乐在迷幻辅助治疗中的作用：神经科学研究、本土致幻仪式与当代护理模式的比较分析
Psychedelic Med (New Rochelle). 2024 Dec 2;2(4):221-233. doi: 10.1089/psymed.2023.0058. eCollection 2024 Dec.
4
Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.探索裸盖菇素辅助心理治疗饮食失调的神经生物学相关性：潜在方法综述及其对迷幻剂研究设计的启示
J Eat Disord. 2024 Dec 27;12(1):214. doi: 10.1186/s40337-024-01185-8.
5
Psychedelics and the treatment of eating disorders: considerations for future research and practice.迷幻剂与饮食失调的治疗：对未来研究与实践的思考
J Eat Disord. 2024 Oct 22;12(1):165. doi: 10.1186/s40337-024-01125-6.
6
History, Hype, and Responsible Psychedelic Medicine: A Qualitative Study of Psychedelic Researchers.历史、炒作与负责任的迷幻药医学：对迷幻药研究人员的定性研究
J Bioeth Inq. 2024 Oct 4. doi: 10.1007/s11673-024-10386-4.
7
Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.迷幻蘑菇对雌雄小鼠体重、身体成分和代谢物的影响。
Physiol Behav. 2024 Oct 1;284:114627. doi: 10.1016/j.physbeh.2024.114627. Epub 2024 Jul 2.
8
If psychedelics heal, how do they do it?如果迷幻药具有治疗作用，它们是如何做到的呢？
Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2321906121. doi: 10.1073/pnas.2321906121. Epub 2024 Jan 3.
9
Complexities of psychedelics for therapeutic use in obesity and eating disorders.用于肥胖症和饮食失调治疗的迷幻剂的复杂性。
J Psychiatry Neurosci. 2022 Oct 25;47(5):E366. doi: 10.1503/jpn.220135-l. Print 2022 Sep-Oct.
本文引用的文献
1
Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.对最近的证据（迷幻蘑菇能“解放”抑郁的心灵）持怀疑态度。
ACS Chem Neurosci. 2022 Sep 7;13(17):2540-2543. doi: 10.1021/acschemneuro.2c00461. Epub 2022 Aug 24.
2
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.迷幻剂：治疗情绪和焦虑障碍的替代和潜在治疗选择。
Molecules. 2022 Apr 14;27(8):2520. doi: 10.3390/molecules27082520.
3
Increased global integration in the brain after psilocybin therapy for depression.抑郁的迷幻蘑菇治疗后大脑中全球整合的增加。
Nat Med. 2022 Apr;28(4):844-851. doi: 10.1038/s41591-022-01744-z. Epub 2022 Apr 11.
4
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.致幻剂诱导神经可塑性的生化机制。
Biochemistry. 2022 Feb 1;61(3):127-136. doi: 10.1021/acs.biochem.1c00812. Epub 2022 Jan 21.
5
Eating disorders and subsequent risk of substance use disorders involving illicit drugs: a Danish nationwide register-based cohort study.进食障碍与随后涉及非法药物的物质使用障碍风险：一项丹麦全国基于登记的队列研究。
Soc Psychiatry Psychiatr Epidemiol. 2022 Apr;57(4):695-708. doi: 10.1007/s00127-021-02201-x. Epub 2022 Jan 5.
6
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.迷幻蘑菇疗法可增加重度抑郁症患者的认知和神经灵活性。
Transl Psychiatry. 2021 Nov 8;11(1):574. doi: 10.1038/s41398-021-01706-y.
7
Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".“裸盖菇素治疗神经性厌食症：一项初步研究”的研究方案
Front Psychiatry. 2021 Oct 20;12:735523. doi: 10.3389/fpsyt.2021.735523. eCollection 2021.
8
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.神经可塑性作为氯胺酮和经典迷幻剂的汇聚机制。
Trends Pharmacol Sci. 2021 Nov;42(11):929-942. doi: 10.1016/j.tips.2021.08.003. Epub 2021 Sep 24.
9
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.裸盖菇素在体内诱导前额叶皮层树突棘的快速和持久生长。
Neuron. 2021 Aug 18;109(16):2535-2544.e4. doi: 10.1016/j.neuron.2021.06.008. Epub 2021 Jul 5.
10
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.MDMA 辅助治疗严重 PTSD：一项随机、双盲、安慰剂对照的 3 期研究。
Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10.
Zotero 插件